first approval for rivastigmin in switzerland

22 MARKET NEWS First approval for rivastigmin in Switzerland IKS, the regulatory authority in Switzerland, has approved rivastigmin ['Exelon'; Novartis] for the treatment of mild-to-moderately severe Alzheimer's disease. The approval of rivastigmin was made via the Swiss regulatory authority's fast-track approvals procedure for treatments of life-threatening diseases. Twice-daily administration Novartis claim that rivastigmin is superior to other acetylcholinesterase inhibitors, as it confers benefit in patients' global functioning, cognition and activities of daily living. The drug is administered twice daily. Rivastigmin is only the third drug to be approved for the treatment of patients with Alzheimer's disease, reports Scrip. EC approval for Novartis's Exelon. Scrip '2:157: 18, 12 Aug 1997 Inpharma e 23 Aug 1997 No, 1101 1173-8324197/1101-000221$01.00° Adl.lnternatlonal Llmitecl19117, All rlghU r_rvecI

Post on 13-Dec-2016

217 views

Category:

Documents

1 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: First approval for rivastigmin in Switzerland

22 MARKET NEWS First approval for rivastigmin in Switzerland

IKS, the regulatory authority in Switzerland, has approved rivastigmin ['Exelon'; Novartis] for the treatment of mild-to-moderately severe Alzheimer's disease. The approval of rivastigmin was made via the Swiss regulatory authority's fast-track approvals procedure for treatments of life-threatening diseases.

Twice-daily administration Novartis claim that rivastigmin is superior to other

acetylcholinesterase inhibitors, as it confers benefit in patients' global functioning, cognition and activities of daily living. The drug is administered twice daily.

Rivastigmin is only the third drug to be approved for the treatment of patients with Alzheimer's disease, reports Scrip. EC approval for Novartis's Exelon. Scrip '2:157: 18, 12 Aug 1997

Inpharmae 23 Aug 1997 No, 1101 1173-8324197/1101-000221$01.00° Adl.lnternatlonal Llmitecl19117, All rlghU r_rvecI

ABB University Switzerland Course Program 2014 … ABB University Switzerland | Course Program 2014 ABB University Switzerland Enrolment form To ABB University Switzerland Administration

Heroin assisted treatment in Switzerland the picture now · medical prescription of heroin › Drug registration, approval and listing ®(Diaphin ) › Health insurance: definitive

PHARMA HUB SWITZERLAND 2030 · Interpharma Pharma hub Switzerland 2030 Interpharma Pharma hub Switzerland 2030 2 3 Switzerland needs ... important pillar and driving force on both

Clarity on Business Location Switzerland...Switzerland Clarity on Business Location Switzerland 1 4 Key findings Roundtable discussion 10 Is Switzerland ready for business transformation?

Suzy meets Switzerland - Switzerland meets Silicon Valley

Study Abroad Switzerland, Study Abroad Consultants for Switzerland, Switzerland Education Consultants in Hyderabad

Science-Switzerland , June – July 2017...Swiss applications have had an approval rate of 24 percent, compared to an 11 percent European average. In total, Switzerland received 520

Switzerland - Lausanne

Kolinesteraz İnhibitörleri Donepezil 5 mgx 1 /gün 4/6 hafta 5 mgx2/gün Rivastigmin

Switzerland powerpoint

Switzerland - Interlaken